Trial Profile
Antiplatelet treatment in patients with diabetes mellitus: is there a difference between aspirin, clopidogrel and prasugrel
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Oct 2022
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Aspirin; Clopidogrel
- Indications Cardiovascular disorders; Thrombosis
- Focus Therapeutic Use
- 18 Oct 2013 Accrual to date is 128% according to United Kingdom Clinical Research Network.
- 10 Oct 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 05 Jun 2013 Accrual to date is 128% according to United Kingdom Clinical Research Network.